试点建立一个扩展平台,用于生产高质量的人类T细胞
Viknesvaran Selvarajan1, Denise Bei Lin Teo1, Chaw-Chiea Chang2
1Food, Chemical and Biotechnology, Singapore Institute of Technology, Singapore, Singapore.
Frontiers in cell and developmental biology
|July 29, 2024
概括
这项研究优化了采用T细胞治疗的制造. 它确定了可扩展,可再生的高质量T细胞生产的关键培养条件,这对于推进癌症治疗至关重要.
科学领域:
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
- 在瘤学瘤学.
背景情况:
- 收养细胞疗法 (ACT) 是一种有前途的癌症治疗方法,CAR-T产品推动了市场的增长.
- 标准化ACT制造对于可访问性和可重复性至关重要.
- 了解T细胞培养条件对于有效扩张和分化至关重要.
研究的目的:
- 评估采用T细胞培养平台的大规模生产.
- 为了确定最佳条件,以获得高质量的细胞输出与最小的细胞死亡.
- 为应对ACT制造中的可扩展性和可重复性挑战.
主要方法:
- 评估了各种采用T细胞培养平台.
- 检查了生物反应器参数,介质,补充剂和刺激.
- 专注于实现大规模生产 (数十亿个细胞) 和高质量的输出.
主要成果:
- 确定了影响T细胞扩张和分化的关键因素.
- 证明了大规模,可复制的T细胞制造的潜力.
- 在评估的平台上实现高质量的细胞输出与最小的细胞死亡.
结论:
- 优化细胞培养条件对于强大的ACT制造至关重要.
- 可扩展和可重复的ACT生产是可以实现的.
- 这项研究支持ACT作为一种实用的癌症治疗方法的发展.
相关概念视频
Scale-Up Processes
105
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
105
Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97


